CELU
Celularity Inc
NASDAQ: CELU · HEALTHCARE · BIOTECHNOLOGY
$0.93
-2.68% today
Updated 2026-04-30
Market cap
$32.01M
P/E ratio
—
P/S ratio
0.79x
EPS (TTM)
$-3.33
Dividend yield
—
52W range
$1 – $4
Volume
0.2M
Celularity Inc (CELU) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-198.80%
Operating margin
-243.20%
ROE
-6,367.00%
ROA
-25.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $17.55M | $-1098.00 | 62.66% | -0.01% | -0.01% |
| 2019 | $21.15M | $-211.88M | 70.10% | -1,249.01% | -1,001.94% |
| 2020 | $14.28M | $-208.23M | 65.46% | -1,064.05% | -1,458.42% |
| 2021 | $21.34M | $-100.12M | 54.76% | -511.17% | -469.27% |
| 2022 | $17.98M | $14.19M | -9.40% | -142.42% | 78.95% |
| 2023 | $22.77M | $-196.29M | 29.66% | -335.86% | -862.04% |
| 2024 | $54.22M | $-57.89M | 72.36% | -70.75% | -106.77% |